Trademark: 79179809
Word
GEMS
Status Date
Saturday, September 9, 2023
Registration Number
5111632
Registration Date
Tuesday, January 3, 2017
Filing Date
Friday, November 20, 2015
Published for Opposition
Tuesday, October 18, 2016
5 Culture media for medical use for use to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes for medical purposes; cell culture media for medical use for use to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes for medical purposes; human cell products, namely, pluripotent and differentiated human cells and stem cells for medical or clinical use; cell culture media for use in medical or medical research applications for cultivating human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes; biological and chemical products and substances for medical use, namely, chemicals for medical or clinical use in relation to assisted reproductive therapies, cell fertilization, cell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and reproduction, chemical preparations for medical or clinical use in relation to assisted reproductive therapies, cell fertilization, cell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and human reproduction, chemical preparations for the treatment of infertility and other disorders relating to fertility and human reproduction, biological preparations for the treatment of infertility and other disorders relating to fertility and human reproduction, biological preparations to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, chemical preparations to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, chemical reagents for medical use in relation to assisted reproductive therapies, cell fertilization, cell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and reproduction; pharmaceutical preparations for the treatment of infertility and other disorders relating to fertility and human reproduction
1 Cell culture media other than for medical or veterinary use, namely, for laboratory use in relation to researching, diagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilization, division and cultivation; cell culture media other than for medical or veterinary use, namely, for scientific and research use in relation to researching, diagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilization, division and cultivation; human cell products, namely, pluripotent and differentiated human cells and stem cells for research or scientific purposes; human cell products, namely, pluripotent and differentiated human cells and stem cells for laboratory use excluding medical and veterinary use; biological and chemical products and substances for scientific use other than for medical or veterinary use, namely, chemicals for use in science in relation to researching, diagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilization, division and cultivation, chemical preparations for scientific purposes in relation to researching, diagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilization, division and cultivation, biological preparations to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, chemical preparations to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, chemical reagents for scientific use in relation to researching, diagnosing and/or treating fertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilization, division and cultivation
Color is not claimed as a feature of the mark.
Sep 9, 2023
Notice Of Acceptance Of Sec. 71 - E-Mailed
Sep 9, 2023
Registered-Sec.71 Accepted
Sep 8, 2023
Case Assigned To Post Registration Paralegal
Feb 20, 2023
Teas Section 71 Received
Jan 7, 2022
New Representative At Ib Received
Jan 3, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Feb 15, 2019
New Representative At Ib Received
Jan 18, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 18, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 22, 2017
Final Decision Transaction Processed By Ib
Apr 4, 2017
Final Disposition Notice Sent To Ib
Apr 4, 2017
Final Disposition Processed
Apr 3, 2017
Final Disposition Notice Created, To Be Sent To Ib
Jan 3, 2017
Registered-Principal Register
Dec 2, 2016
Notification Of Possible Opposition - Processed By Ib
Nov 15, 2016
Assigned To Examiner
Oct 18, 2016
Official Gazette Publication Confirmation E-Mailed
Oct 18, 2016
Published For Opposition
Sep 28, 2016
Notification Of Possible Opposition Sent To Ib
Sep 28, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 28, 2016
Notification Of Notice Of Publication E-Mailed
Sep 14, 2016
Law Office Publication Review Completed
Sep 9, 2016
Approved For Pub - Principal Register
Sep 2, 2016
Teas/Email Correspondence Entered
Sep 2, 2016
Correspondence Received In Law Office
Sep 2, 2016
Assigned To Lie
Aug 29, 2016
Teas Response To Office Action Received
Aug 25, 2016
Teas Change Of Correspondence Received
Jul 1, 2016
Change Of Owner Received From Ib
Mar 19, 2016
Refusal Processed By Ib
Mar 1, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Mar 1, 2016
Refusal Processed By Mpu
Mar 1, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Feb 29, 2016
Non-Final Action Written
Feb 24, 2016
Assigned To Examiner
Jan 9, 2016
Application Filing Receipt Mailed
Jan 5, 2016
New Application Office Supplied Data Entered
Jan 3, 2016
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
